The weekly litigation news digest is live. Subscribe now

IP Verse

Gedeon Richter Pharma competitive analysis

Loading summary...

Latest oppositions filed by Gedeon Richter Pharma

Explore patent oppositions filed by Gedeon Richter Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 20, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4019041
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIASep 28, 2023
EP2578231
Antitumor T Cell Response EnhancerCHUGAI SEIYAKU KABUSHIKI KAISHAJul 25, 2023
EP3433276
Early Intervention Methods To Prevent Or Ameliorate ToxicitySEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RESEARCH INSTITUTESep 20, 2022
EP2872171
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIAOct 6, 2021
EP3338794
Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIANov 25, 2020

Latest PTAB cases involving Gedeon Richter Pharma

Discover the latest PTAB cases involving Gedeon Richter Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Gedeon Richter Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GEDEON RICHTER PHARMA5 - - -
CHUGAI SEIYAKU KABUSHIKI KAISHA378 - 1
THE CHILDRENS HOSPITAL OF PHILADELPHIA - 19 - -
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA - 38 - 7